Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 03, 2025 04:23 ET | Source: Research and Markets

Pazopanib Generics Market Analysis and Forecast 2025-2030: Regional Variances in Regulatory and Reimbursement Frameworks Demand Tailored Market Entry Strategies

Dublin, Sept. 03, 2025 (GLOBE NEWSWIRE) -- The "Pazopanib Generics Market by Application (Ovarian Cancer, Renal Cell Carcinoma, Soft Tissue Sarcoma), Dosage Form (Capsule, Injectable, Tablet), Route...
August 06, 2025 04:09 ET | Source: Research and Markets

Docetaxel Market Growth Trends, Competitive Strategies and Forecasts, 2025-2033 | Generics Dominate Docetaxel Market with Cost-Effective Solutions Post Patent Expiry

Dublin, Aug. 06, 2025 (GLOBE NEWSWIRE) -- The "Docetaxel Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2025 To...
April 23, 2025 11:18 ET | Source: Research and Markets

Sorafenib Market and Companies Analysis Report 2025: Features Key Players - Pfizer, Bayer, AstraZeneca, Novartis, Bristol Myers Squibb & More

Dublin, April 23, 2025 (GLOBE NEWSWIRE) -- The "Sorafenib Market Report 2025" has been added to ResearchAndMarkets.com's offering.This Sorafenib market report provides a comprehensive analysis of...
April 16, 2025 04:22 ET | Source: Research and Markets

Thyroid Cancer Drugs Industry and Companies Analysis Report 2025: A $2.2 Billion Landscape by 2029

Dublin, April 16, 2025 (GLOBE NEWSWIRE) -- The "Thyroid Cancer Drugs Market Report 2025" has been added to ResearchAndMarkets.com's offering. The thyroid cancer drugs market has demonstrated...
March 24, 2025 10:31 ET | Source: Research and Markets

Lenalidomide (CAS 191732-72-6) Industry Report 2025: Global and Regional Market Trends 2019-2024 and Forecasts 2025-2029 - Manufacturers, Market Prices, Patents, Down-stream Industries

Dublin, March 24, 2025 (GLOBE NEWSWIRE) -- The "Lenalidomide (CAS 191732-72-6) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029" report has been added to ...
February 10, 2025 06:28 ET | Source: Research and Markets

Doxorubicin Global Industry Report 2025 - Doxorubicin Market Projected to Reach US$1.7 Billion by 2030

Dublin, Feb. 10, 2025 (GLOBE NEWSWIRE) -- The "Doxorubicin - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Doxorubicin was valued at...
January 13, 2025 11:54 ET | Source: Research and Markets

Liposomal Doxorubicin Market Research and Forecast Report 2024-2032: Growing Investments and Collaborations, Personalised Medicine Trends, Market Penetration in Emerging Economies

Dublin, Jan. 13, 2025 (GLOBE NEWSWIRE) -- The "Liposomal Doxorubicin Market Report and Forecast 2024-2032" report has been added to ResearchAndMarkets.com's offering.The global liposomal...
November 11, 2024 11:04 ET | Source: Research and Markets

Sunitinib Malate Global Strategic Business Report 2024-2030: Emerging Clinical Trials for Combination Therapies Propels Competitiveness

Dublin, Nov. 11, 2024 (GLOBE NEWSWIRE) -- The "Sunitinib Malate - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Sunitinib Malate...
November 07, 2024 08:04 ET | Source: Research and Markets

Liposomal Doxorubicin Market Report 2024-2032: Innovative Liposomal Formulations Pave the Way for Safer and More Effective Cancer Treatments

Dublin, Nov. 07, 2024 (GLOBE NEWSWIRE) -- The "Liposomal Doxorubicin Market Report and Forecast 2024-2032" report has been added to ResearchAndMarkets.com's offering.The global liposomal...
September 30, 2024 05:50 ET | Source: Research and Markets

$1.89 Bn Liposomal Doxorubicin Markets, 2024-2030: Focus on Doxil/Caelyx, Lipodox, and Myocet

Dublin, Sept. 30, 2024 (GLOBE NEWSWIRE) -- The "Liposomal Doxorubicin Market Size, Share & Trends Analysis Report By Product, By Application (Multiple Myeloma, Ovarian Cancer, Breast Cancer), By...